Fenizia Claudio

RICERCATORE A TEMPO DETERMINATO (Lettera A)
SSD
MED/04 - PATOLOGIA GENERALE
Settore concorsuale
06/A2 - PATOLOGIA GENERALE E PATOLOGIA CLINICA

Contatti

Sede di lavoro

Via Fratelli Cervi, 93
20090 SEGRATE (MI)

Via Gian Battista Grassi, 74
20157 MILANO (MI)

E-mail di ateneo

Didattica

Ricerca

Pubblicazioni
  • Analysing the role of STAT3 in HIV-1 infection / S.V. Ibba, C. Fenizia, P. Serna Ortega, V. Mercurio, I. Saulle, E.M. Lori, D. Trabattoni, M. Clerici, M. Biasin. - In: JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS. - ISSN 0393-974X. - 33:5(2019 Oct), pp. 1635-1640.
  • Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) is released in the secretome of activated MDMs and reduces in vitro HIV-1 infection / I. Saulle, S.V. Ibba, E. Torretta, C. Vittori, C. Fenizia, F. Piancone, D. Minisci, E.M. Lori, D. Trabattoni, C. Gelfi, M. Clerici, M. Biasin. - In: FRONTIERS IN IMMUNOLOGY. - ISSN 1664-3224. - 10(2019 Jul), pp. 1648.1-1648.11.
  • SMYD3 promotes the epithelial-mesenchymal transition in breast cancer / C. Fenizia, C. Bottino, S. Corbetta, R. Fittipaldi, P. Floris, G. Gaudenzi, S. Carra, F. Cotelli, G. Vitale, G. Caretti. - In: NUCLEIC ACIDS RESEARCH. - ISSN 0305-1048. - (2018 Dec 14), pp. gky1221.1-gky1221.16. [Epub ahead of print]
  • The interleukin 21 (IL 21)/ microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection / P.A.S. Ortega, I. Saulle, V. Mercurio, S.V. Ibba, E.M. Lori, C. Fenizia, M. Masetti, D. Trabattoni, S.L. Caputo, F. Vichi, F. Mazzotta, M. Clerici, M. Biasin. - In: AIDS. - ISSN 0269-9370. - 32:17(2018 Nov 13), pp. 2453-2461.
  • Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine / M. Omsland, C. Pise-Masison, D. Fujikawa, V. Galli, C. Fenizia, R.W. Parks, B.T. Gjertsen, G. Franchini, V. Andresen. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 8:1(2018), pp. 11118.1-11118.17.